These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37501932)

  • 41. Long noncoding RNA TCL6 binds to miR-106a-5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathway.
    Luo LH; Jin M; Wang LQ; Xu GJ; Lin ZY; Yu DD; Yang SL; Ran RZ; Wu G; Zhang T
    J Cell Physiol; 2020 Sep; 235(9):6154-6166. PubMed ID: 32020591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211.
    Ji L; Li X
    J Cell Physiol; 2019 Dec; 234(12):22911-22920. PubMed ID: 31124134
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1.
    Zhang G; He X; Ren C; Lin J; Wang Q
    J Cell Physiol; 2019 Aug; 234(8):13097-13109. PubMed ID: 30569456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hox transcript antisense RNA knockdown inhibits osteosarcoma progression by regulating the phosphoinositide 3-kinase/AKT pathway through the microRNA miR-6888-3p/spleen tyrosine kinase axis.
    Wu W; Wang L; Li S
    Bioengineered; 2022 Apr; 13(4):9397-9410. PubMed ID: 35435107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long noncoding RNA TUG1 decreases bladder cancer chemo-sensitivity toward doxorubicin through elevating KPNA2 expression and activating the PI3K/AKT pathway via adsorbing miR-582-5p.
    Lu P; Jiang Y; Xia Z
    Anticancer Drugs; 2023 Jan; 34(1):144-154. PubMed ID: 36539367
    [TBL] [Abstract][Full Text] [Related]  

  • 46. LncRNA PSMA3-AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR-378a-3p/GALNT3 axis.
    Xu Z; Jin H; Duan X; Liu H; Zhao X; Fan S; Wang Y; Yao T
    Environ Toxicol; 2021 Dec; 36(12):2562-2577. PubMed ID: 34520102
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Downregulation of NEAT1 reverses the radioactive iodine resistance of papillary thyroid carcinoma cell via miR-101-3p/FN1/PI3K-AKT signaling pathway.
    Liu C; Feng Z; Chen T; Lv J; Liu P; Jia L; Zhu J; Chen F; Yang C; Deng Z
    Cell Cycle; 2019 Jan; 18(2):167-203. PubMed ID: 30596336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MiR-18a-5p attenuates HER2-positive breast cancer development by regulating PI3K/AKT pathway.
    Liu Y; Yang H
    Cancer Biol Ther; 2023 Dec; 24(1):2224512. PubMed ID: 37394766
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.
    Nie ZC; Weng WH; Shang YS; Long Y; Li J; Xu YT; Li Z
    Int J Clin Exp Pathol; 2015; 8(5):4745-54. PubMed ID: 26191164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long non-coding RNA LINC00958 promotes colorectal cancer progression by enhancing the expression of LEM domain containing 1 via microRNA miR-3064-5p.
    Luo Z; Hao S; Yuan J; Zhu K; Liu S; Zhang J; Yao L
    Bioengineered; 2021 Dec; 12(1):8100-8115. PubMed ID: 34672237
    [TBL] [Abstract][Full Text] [Related]  

  • 51. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
    Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L
    Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Downregulation of miR-99b-5p and Upregulation of Nuclear mTOR Cooperatively Promotes the Tumor Aggressiveness and Drug Resistance in African American Prostate Cancer.
    Gujrati H; Ha S; Waseem M; Wang BD
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncogenic gene RGC-32 is a direct target of miR-26b and facilitates tongue squamous cell carcinoma aggressiveness through EMT and PI3K/AKT signalling.
    Yang ZH; Li J; Chen WZ; Kong FS
    Cell Biochem Funct; 2020 Oct; 38(7):943-954. PubMed ID: 32325539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long noncoding RNA ILF3-AS1 regulates myocardial infarction via the miR-212-3p/SIRT1 axis and PI3K/Akt signaling pathway.
    Zhang JY; Yang Z; Fang K; Shi ZL; Ren DH; Sun J
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2647-2658. PubMed ID: 32196615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long Noncoding RNA SOX2-OT Knockdown Inhibits Proliferation and Metastasis of Prostate Cancer Cells Through Modulating the miR-452-5p/HMGB3 Axis and Inactivating Wnt/β-Catenin Pathway.
    Song X; Wang H; Wu J; Sun Y
    Cancer Biother Radiopharm; 2020 Nov; 35(9):682-695. PubMed ID: 32407168
    [No Abstract]   [Full Text] [Related]  

  • 57. LncRNA HOTAIR facilitates proliferation and represses apoptosis of retinoblastoma cells through the miR-20b-5p/RRM2/PI3K/AKT axis.
    Fu K; Zhang K; Zhang X
    Orphanet J Rare Dis; 2022 Mar; 17(1):119. PubMed ID: 35248107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET/PI3K/AKT pathway.
    Sun ZY; Jian YK; Zhu HY; Li B
    Pathol Res Pract; 2019 Mar; 215(3):555-563. PubMed ID: 30661902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Down-regulated microRNA-223 or elevated ZIC1 inhibits the development of pancreatic cancer via inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zhu J; Lv J; Chen J; Zhang X; Ji Y
    Cell Cycle; 2020 Nov; 19(21):2851-2865. PubMed ID: 33064959
    [No Abstract]   [Full Text] [Related]  

  • 60. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
    Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.